{
    "clinical_study": {
        "@rank": "53552", 
        "arm_group": [
            {
                "arm_group_label": "Posaconazole", 
                "arm_group_type": "Experimental", 
                "description": "Participants will start therapy with a posaconazole loading dose of 300 mg intravenously (IV) twice per day (BID) on Day 1, and then will receive posaconazole IV 300 mg once per day (QD) starting on Day 2 until clinically stable when participants will transition to oral therapy with posaconazole 300 mg tablets QD for up to a total of 12 weeks of treatment. Participants with renal insufficiency or without central venous catheter access may start study treatment with a loading dose of oral posaconazole 300 mg tablets BID on Day 1, and then 300 mg QD for up to a total of 12 weeks of treatment."
            }, 
            {
                "arm_group_label": "Voriconazole", 
                "arm_group_type": "Active Comparator", 
                "description": "Participants will start therapy with a voriconazole loading dose of 6 mg/kg of body weight IV BID on Day 1, and then will receive voriconazole IV 4 mg/kg of body weight IV BID starting on Day 2 until clinically stable when participants will transition to oral therapy with voriconazole 200 mg capsules BID for up to a total of 12 weeks of treatment. Participants with renal insufficiency or without central venous catheter access may start study treatment with a loading dose of oral voriconazole 300 mg capsules BID on Day 1, and then 200 mg BID for up to a total of 12 weeks of treatment."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the safety and efficacy of posaconazole versus\n      voriconazole in the treatment of adults with invasive aspergillosis (IA)."
        }, 
        "brief_title": "A Study of the Safety and Efficacy of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis (MK-5592-069/P06200)", 
        "completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Fungal Infections", 
        "condition_browse": {
            "mesh_term": [
                "Aspergillosis", 
                "Mycoses"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Weight >40 kg (88 lb) and \u2264150 kg (330 lb)\n\n          -  Acute IA defined as duration of clinical syndrome of <30 days.\n\n          -  Female subjects of child-bearing potential must be using a medically accepted method\n             of birth control before beginning study-drug treatment and agree to continue its use\n             for 30 days after stopping study medication.\n\n        Exclusion Criteria:\n\n          -  Chronic (>1 month duration) IA, relapsed/recurrent IA, or refractory IA\n\n        which has not responded to antifungal therapy.\n\n          -  Sarcoidosis, aspergilloma, or allergic bronchopulmonary aspergillosis (ABPA).\n\n          -  Known mixed invasive mold fungal infection including Zygomycetes, and/or a known\n             invasive Aspergillus fungal infection in which either study drug may not be\n             considered active.\n\n          -  Receipt of any systemic (oral, intravenous, or inhaled) antifungal therapy for this\n             infection episode for 4 or more consecutive days immediately before randomization.\n\n          -  Developed the current episode of IA infection during receipt of >13 days of\n             antifungal prophylaxis with an agent considered to be a mold-active antifungal agent.\n\n          -  Receipt of posaconazole or voriconazole as empirical treatment for this infection for\n             4 days (96 hours) or more within the 15 days immediately before randomization.\n\n          -  Known hypersensitivity or other serious adverse reaction to any azole antifungal\n             therapy or to any other ingredient of the study medication used.\n\n          -  Females who are pregnant, intend to become pregnant, or are nursing at the time of\n             randomization.\n\n          -  Known history of Torsade de Pointes, unstable cardiac arrhythmia or proarrhythmic\n             conditions, or a history of recent myocardial infarction within 90 days of study\n             entry.\n\n          -  Hepatic cirrhosis or a Child-Pugh score of C (severe hepatic impairment) at the time\n             of randomization.\n\n          -  Severe renal insufficiency (estimated creatinine clearance <20 mL/min) or on\n\n        hemodialysis at the time of randomization or likely to require dialysis during the study.\n\n          -  Known hereditary problem of galactose intolerance, Lapp lactase deficiency, or\n             glucose-galactose malabsorption.\n\n          -  Acute symptomatic pancreatitis within 6 months of study entry or a diagnosis of\n             chronic pancreatitis at the time of randomization.\n\n          -  Active skin lesion consistent with squamous cell carcinoma at the time of\n             randomization, or a current or prior history of malignant melanoma within 5 years of\n             study entry.\n\n          -  On artificial ventilation or receiving acute Continuous Positive Airway Pressure\n             (CPAP)/Bilevel Positive Airway Pressure (BPAP) at the time of randomization.\n\n          -  Known or suspected Gilbert's disease at the time of randomization.\n\n          -  Requires treatment with other medications that cannot be stopped and for which there\n             is a known contraindication to co-administration of one or more of the study drugs."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01782131", 
            "org_study_id": "P06200", 
            "secondary_id": [
                "2011-003938-14", 
                "5592-069"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "Posaconazole", 
                "intervention_name": "Posaconazole", 
                "intervention_type": "Drug", 
                "other_name": [
                    "SCH 056592", 
                    "MK-5592", 
                    "Noxafil\u00ae"
                ]
            }, 
            {
                "arm_group_label": "Voriconazole", 
                "intervention_name": "Voriconazole", 
                "intervention_type": "Drug", 
                "other_name": "VFEND\u00ae"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Voriconazole", 
                "Posaconazole"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "May 8, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35294"
                    }, 
                    "name": "Call for Information (Investigational Site 0010)"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Gainesville", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32610"
                    }, 
                    "name": "Call for Information (Investigational Site 0003)"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "Call for Information (Investigational Site 0250)"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48202"
                    }, 
                    "name": "Call for Information (Investigational Site 0253)"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "10065"
                    }, 
                    "name": "Call for Information (Investigational Site 0017)"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charleston", 
                        "country": "United States", 
                        "state": "South Carolina", 
                        "zip": "29425"
                    }, 
                    "name": "Call for Information (Investigational Site 0254)"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77030"
                    }, 
                    "name": "Call for Information (Investigational Site 0022)"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Alfredo Wilkinson", 
                    "phone": "54 11 4796 8200"
                }, 
                "facility": {
                    "address": {
                        "city": "Buenos Aires", 
                        "country": "Argentina"
                    }, 
                    "name": "Merck Sharp & Dohme (Argentina) Inc."
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Danny D'Hulster", 
                    "phone": "32 23734310"
                }, 
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium"
                    }, 
                    "name": "MSD Belgium BVBA/SPRL"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Medical Information Centre / Centre de l'information medicale de Merck Canada", 
                    "phone": "514-428-8600 / 1-800-567-2594"
                }, 
                "facility": {
                    "address": {
                        "city": "Kirkland", 
                        "country": "Canada", 
                        "state": "Quebec", 
                        "zip": "H9H 3L1"
                    }, 
                    "name": "Merck Canada"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Maria Elena Azara Hernandez", 
                    "phone": "56 2 6558958"
                }, 
                "facility": {
                    "address": {
                        "city": "Santiago", 
                        "country": "Chile"
                    }, 
                    "name": "Merck Sharp & Dohme (I.A.) Corp."
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Andrius Bacevicius", 
                    "phone": "370 52780243"
                }, 
                "facility": {
                    "address": {
                        "city": "Tallinn", 
                        "country": "Estonia"
                    }, 
                    "name": "Merck Sharp & Dohme OU"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Dominique Blazy", 
                    "phone": "33 147548990"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "MSD France"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "German Medical Information Center", 
                    "phone": "49 800 673 673 673"
                }, 
                "facility": {
                    "address": {
                        "city": "Haar", 
                        "country": "Germany"
                    }, 
                    "name": "Merck Sharp & Dohme GmbH"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Ofer Sharon", 
                    "phone": "972 9 9539310"
                }, 
                "facility": {
                    "address": {
                        "city": "Hod Hasharon", 
                        "country": "Israel"
                    }, 
                    "name": "Merck Sharp & Dohme Co. Ltd."
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Patrizia Nardini", 
                    "phone": "39 06 361911"
                }, 
                "facility": {
                    "address": {
                        "city": "Rome", 
                        "country": "Italy"
                    }, 
                    "name": "MSD Italia S.r.l."
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Cem Ozesen", 
                    "phone": "90 212 3361260"
                }, 
                "facility": {
                    "address": {
                        "city": "Seoul", 
                        "country": "Korea, Republic of"
                    }, 
                    "name": "MSD Korea LTD"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Andrius Bacevicius", 
                    "phone": "370 52780243"
                }, 
                "facility": {
                    "address": {
                        "city": "Vilnius", 
                        "country": "Lithuania"
                    }, 
                    "name": "UAB \"Merck Sharp & Dohme\""
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Boon Hock Yeoh", 
                    "phone": "60 377181723"
                }, 
                "facility": {
                    "address": {
                        "city": "Petaling Jaya", 
                        "country": "Malaysia"
                    }, 
                    "name": "MSD"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Ana Maria Nogueira", 
                    "phone": "351-21-4465890"
                }, 
                "facility": {
                    "address": {
                        "city": "Paco D'arcos", 
                        "country": "Portugal"
                    }, 
                    "name": "Merck Sharp & Dohme Lda."
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Maria Koroleva", 
                    "phone": "7 0959410000"
                }, 
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Merck Sharp & Dohme IDEA, Inc."
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Cesar Sanz Rodriguez", 
                    "phone": "34 913210600"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Merck Sharp and Dohme de Espana S.A."
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Erik Mossdorf", 
                    "phone": "41 58 618 33 79"
                }, 
                "facility": {
                    "address": {
                        "city": "Lucerne 6", 
                        "country": "Switzerland"
                    }, 
                    "name": "MSD International GmbH"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Alev Eren", 
                    "phone": "90 212 336 12 63"
                }, 
                "facility": {
                    "address": {
                        "city": "Istanbul", 
                        "country": "Turkey"
                    }, 
                    "name": "Merck Sharp & Dohme Ilaclari Ltd. Sti"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Argentina", 
                "Belgium", 
                "Canada", 
                "Chile", 
                "Estonia", 
                "France", 
                "Germany", 
                "Israel", 
                "Italy", 
                "Korea, Republic of", 
                "Lithuania", 
                "Malaysia", 
                "Portugal", 
                "Russian Federation", 
                "Spain", 
                "Switzerland", 
                "Turkey"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase 3 Randomized Study of the Efficacy and Safety of Posaconazole Versus Voriconazole for the Treatment of Invasive Aspergillosis in Adults (Phase 3; Protocol No. MK-5592-069)", 
        "overall_contact": {
            "last_name": "Toll Free Number", 
            "phone": "1-888-577-8839"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Number of Participants Achieving Global Clinical Response at Week 6", 
            "safety_issue": "No", 
            "time_frame": "Week 6"
        }, 
        "removed_countries": {
            "country": [
                "Peru", 
                "Colombia", 
                "Singapore"
            ]
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01782131"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Number of Participants Achieving Global Clinical Response at Week 12", 
                "safety_issue": "No", 
                "time_frame": "Week 12"
            }, 
            {
                "measure": "Number of Participants Who Died by Week 6", 
                "safety_issue": "No", 
                "time_frame": "Up to Week 6"
            }, 
            {
                "measure": "Number of Participants Who Died by Week 12", 
                "safety_issue": "No", 
                "time_frame": "Up to Week 12"
            }, 
            {
                "measure": "Time to Clinical Global Response", 
                "safety_issue": "No", 
                "time_frame": "Week 12"
            }, 
            {
                "measure": "Time to Death", 
                "safety_issue": "No", 
                "time_frame": "Up to Week 26"
            }
        ], 
        "source": "Merck Sharp & Dohme Corp.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Merck Sharp & Dohme Corp.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}